Patents Assigned to Biopolymer Engineering (d/b/a Biothera)
  • CANCER THERAPY USING WHOLE GLUCAN PARTICLES AND ANTIBODIES
    Publication number: 20100166751
    Abstract: The present invention relates to methods of using whole glucan particles and complement activating antibodies for antitumor therapy. Whole glucan particles enhance the tumoricidal activity of the innate immune system by binding to the C3 complement protein receptor CR3. This binding enhances innate immune system cytotoxicity, as well as stimulating the release of activating cytokines.
    Type: Application
    Filed: November 9, 2009
    Publication date: July 1, 2010
    Applicants: Biopolymer Engineering (d/b/a Biothera), University of Louisville Research Foundation, Inc.
    Inventors: Gary R. Ostroff, Gordon D. Ross, Trunetta Jo Dockter Ross